Search research articles
Contact Us
Filters
Showing results (291-300 of 312) with videos related to
Page
of 32
Sort By:
Haematologica
|
February 13, 2016
Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia
Sandra Preuner, Christina Peters, Ulrike Pötschger, et al.
American Journal of Hematology
|
June 8, 2026
Correction of Ineffective Erythropoiesis and Normalization of Iron Homeostasis After Exagamglogene Autotemcel in Transfusion-Dependent β-Thalassemia
Sujit Sheth, Selim Corbacioglu, Josu de la Fuente, et al.
Leukemia
|
September 13, 2022
Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL - long-term follow-up from the prospective ALL-SCT 2003 trial
Anna Eichinger, Ulrike Poetschger, Evgenia Glogova, et al.
Leukemia
|
December 7, 2019
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial
Andishe Attarbaschi, Georg Mann, Martin Zimmermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2023
Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial
Tim Flaadt, Ruth L Ladenstein, Martin Ebinger, et al.
The New England Journal of Medicine
|
April 24, 2024
Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia
Franco Locatelli, Peter Lang, Donna Wall, et al.
European Journal of Human Genetics : EJHG
|
July 28, 2023
Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patients
Christopher Schroeder, Ulrike Faust, Luisa Krauße, et al.
Nature Communications
|
July 4, 2023
Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN
Steffen Fuchs, Clara Danßmann, Filippos Klironomos, et al.
Oncoimmunology
|
June 10, 2022
Novel adapter CAR-T cell technology for precisely controllable multiplex cancer targeting
Christian M Seitz, Joerg Mittelstaet, Daniel Atar, et al.
Bone Marrow Transplantation
|
May 16, 2019
Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL
Florian Babor, Christina Peters, Angela R Manser, et al.
Page
of 32
Search research articles
Search
Showing results (291-300 of 312) with videos related to
Sort By:
Page
of 32
Haematologica
|
February 13, 2016
Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia
Sandra Preuner, Christina Peters, Ulrike Pötschger, et al.
American Journal of Hematology
|
June 8, 2026
Correction of Ineffective Erythropoiesis and Normalization of Iron Homeostasis After Exagamglogene Autotemcel in Transfusion-Dependent β-Thalassemia
Sujit Sheth, Selim Corbacioglu, Josu de la Fuente, et al.
Leukemia
|
September 13, 2022
Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL - long-term follow-up from the prospective ALL-SCT 2003 trial
Anna Eichinger, Ulrike Poetschger, Evgenia Glogova, et al.
Leukemia
|
December 7, 2019
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial
Andishe Attarbaschi, Georg Mann, Martin Zimmermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2023
Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial
Tim Flaadt, Ruth L Ladenstein, Martin Ebinger, et al.
The New England Journal of Medicine
|
April 24, 2024
Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia
Franco Locatelli, Peter Lang, Donna Wall, et al.
European Journal of Human Genetics : EJHG
|
July 28, 2023
Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patients
Christopher Schroeder, Ulrike Faust, Luisa Krauße, et al.
Nature Communications
|
July 4, 2023
Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN
Steffen Fuchs, Clara Danßmann, Filippos Klironomos, et al.
Oncoimmunology
|
June 10, 2022
Novel adapter CAR-T cell technology for precisely controllable multiplex cancer targeting
Christian M Seitz, Joerg Mittelstaet, Daniel Atar, et al.
Bone Marrow Transplantation
|
May 16, 2019
Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL
Florian Babor, Christina Peters, Angela R Manser, et al.
Page
of 32